acid ceramidase

Acid Ceramidase-IN-1 是一种可口服且具有良好的脑渗透性的酸性神经酰胺酶 (AC, ASAH-1) 抑制剂。Acid Ceramidase-IN-1 可用于研究神经系统疾病。

ARN14974 是一种有效的全身活性的胞内酸性神经酰胺酶抑制剂 (IC50=79 nM)，是一种苯并恶唑酮甲酰胺化合物。

Acid Ceramidase-IN-2（compound 1）是一款针对酸性神经酰胺酶（ceramidase）的抑制剂，显示出抗增殖及细胞活性抑制的潜力。有研究表明，该化合物在前列腺癌细胞中可阻止人酸性神经酰胺酶的过度表达，从而揭示了其潜在的抗肿瘤能力。此外，Acid Ceramidase-IN-2被三种α-酮酰胺：GT85、GT98和GT99在体外有效抑制其水解作用。

Carmofur (HCFU) 是 5-氟尿嘧啶的衍生物，是一种抗肿瘤药物。它是一种酸性神经酰胺酶抑制剂，用于治疗乳腺癌和结直肠癌。它抑制 SARS-CoV-2主要蛋白酶，还抑制 Vero E6 细胞 SARS-CoV-2，EC50为 24.3 μM。

LCL521 能抑制溶酶体酸性鞘磷脂酶（ASMase）。LCL521 是一种酸性神经酰胺酶(ACDase)抑制剂。

LCL521 dihydrochloride is a compound that functions as an inhibitor of both acid ceramidase (ACDase) and lysosomal acid sphingomyelinase (ASMase).

D-NMAPPD ((1R,2R)-B13) 是一种酸性神经酰胺酶抑制剂，也是神经酰胺类似物，具有潜在的抗增殖活性，可调节人黑色素瘤细胞中神经酰胺信号传导。D-NMAPPD 可用于研究结肠癌。

ARN14988 is a potent inhibitor of acid ceramidase (IC50 = 12.8 nM for the human enzyme). It inhibits acid ceramidase activity and increases levels of C16 dihydro ceramide and C16 ceramide in A375, G361, M14, MeWo, MNT-1, and SK-MEL-28 melanoma cells. ARN14988 also reduces growth of A375 and G361 melanoma cells (EC50s = 41.8 and 67.7 μM, respectively).

SABRAC inhibits acid ceramidase in PC3 MC metastatic prostate cancer cells (IC50 = <1 µM), as well as induces accumulation of ceramides in the same cells.

SOCLAC, a derivative of the acid ceramidase inhibitor SABRAC, functions as an irreversible inhibitor of acid ceramidase with an inhibition constant (Ki) of 40.2 nM.

SOBRAC, a derivative of the acid ceramidase inhibitor SABRAC, acts as an irreversible inhibitor of acid ceramidase (Ki= 29.7 nM).

W000113414_I13是一种酸性神经酰胺酶 (AC) 抑制剂。W000113414_I13 对 AC 具有剂量依赖性抑制作用，IC50值为6.6 μM，可用于癌症研究。